As of the second quarter of 2025, 11 million unique patients were using a GLP-1 across indications, having consistently grown year-over-year
1 For instance, exenatide has a half-life of just a few hours, so youd typically need daily injections
But first here are five signs your body might be asking for one
Access this article Similar content being viewed by others References A Li Z Ni J Zhang Z Cai Y Kuang C Yu 2020 Transferrin insufficiency and iron overload in follicular fluid contribute to oocyte dysmaturity in infertile women with advanced endometriosis Front Endocrinol 11 391 A Martines R Masereeuw H Tjalsma J Hoenderop J Wetzels D Swinkels 2013 Iron metabolism in the pathogenesis of iron-induced kidney injury Nature Rev Nephrol 9 7 385 98 Aristizbal B, Gonzlez
The dual agonism is why tirzepatide produces greater weight loss than semaglutide, a selective GLP-1 agonist, as seen in trials comparing the two agents
The WBC population was separated by hypotonic lysis of erythrocytes with red blood cell lysate (Solarbio, Beijing, China)
